Advertisement
Screener

ACCUSTEM SCIENCES, INC. (ACUT) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum

1.3 / 5 stars · 7/27 Roast Me

ACCUSTEM SCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum

ACCUSTEM SCIENCES, INC. (ACUT) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum of 2.34% for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.

Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum · last filed 2024-03-22

  • ACCUSTEM SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for the quarter ending 2022-03-31 was 2.34%.
  • ACCUSTEM SCIENCES, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate, maximum for fiscal 2022 was 4.20%.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum 12 month
2023-06-302.34%
10-Q · filed 2023-08-14
2022-12-314.20%
10-K · filed 2024-03-22
2022-09-302.34%
10-Q · filed 2023-11-13
2022-06-302.34%
10-Q · filed 2022-08-12
2022-03-312.34%
10-Q · filed 2023-05-05